Rheumatic disorders as paraneoplastic syndromes.

Area of Science:

• Rheumatology and Oncology
• Paraneoplastic Syndromes
• Cancer-Associated Autoimmunity

Background:

• Rheumatologic disorders (RDs) are frequently observed to precede or coincide with various solid and hematological tumors.
• This association offers a critical pathway for the early diagnosis and management of cancers.
• Commonly reported paraneoplastic RDs include inflammatory myopathies, seronegative rheumatoid arthritis, and atypical vasculitides.

Purpose of the Study:

• To review current hypotheses regarding the pathogenesis of tumors presenting as RDs.
• To discuss clinical features that differentiate paraneoplastic RDs from idiopathic RDs.
• To emphasize the diagnostic and therapeutic implications of recognizing paraneoplastic RDs.

Main Methods:

• Literature review of established observations and current research on paraneoplastic rheumatologic disorders.
• Analysis of clinical presentations and pathogenetic hypotheses.
• Synthesis of information to distinguish paraneoplastic from idiopathic RDs.

Main Results:

• The clinical course of paraneoplastic RDs typically mirrors that of the associated cancer.
• Successful treatment of the underlying tumor, via surgery or medical therapy, usually leads to significant improvement in the RD.
• Distinguishing paraneoplastic RDs from idiopathic RDs can be challenging, but atypical clinical features may suggest an underlying malignancy.

Conclusions:

• Recognizing specific rheumatologic disorders as potential paraneoplastic syndromes is crucial for early cancer detection.
• Understanding the pathogenesis and clinical distinctions is key for effective patient management.
• Further research into the mechanisms linking cancer and RDs can improve diagnostic accuracy and therapeutic strategies.